Literature DB >> 29710070

Malignant Abnormalities in Male BRCA Mutation Carriers: Results From a Prospectively Screened Cohort.

Roy Mano1,2, Shlomit Tamir3, Inbal Kedar4, Ofer Benjaminov3, Jack Baniel1,2, Tzlil Tabachnik1, David Margel1,2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29710070      PMCID: PMC6145684          DOI: 10.1001/jamaoncol.2018.0271

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

1.  Cancer risks in BRCA2 mutation carriers.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

Review 2.  Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.

Authors:  Alexander Liede; Beth Y Karlan; Steven A Narod
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

3.  Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; D T Bishop; S A Narod; D E Goldgar
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

4.  Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.

Authors:  Elizabeth K Bancroft; Elizabeth C Page; Elena Castro; Hans Lilja; Andrew Vickers; Daniel Sjoberg; Melissa Assel; Christopher S Foster; Gillian Mitchell; Kate Drew; Lovise Mæhle; Karol Axcrona; D Gareth Evans; Barbara Bulman; Diana Eccles; Donna McBride; Christi van Asperen; Hans Vasen; Lambertus A Kiemeney; Janneke Ringelberg; Cezary Cybulski; Dominika Wokolorczyk; Christina Selkirk; Peter J Hulick; Anders Bojesen; Anne-Bine Skytte; Jimmy Lam; Louise Taylor; Rogier Oldenburg; Ruben Cremers; Gerald Verhaegh; Wendy A van Zelst-Stams; Jan C Oosterwijk; Ignacio Blanco; Monica Salinas; Jackie Cook; Derek J Rosario; Saundra Buys; Tom Conner; Margreet G Ausems; Kai-ren Ong; Jonathan Hoffman; Susan Domchek; Jacquelyn Powers; Manuel R Teixeira; Sofia Maia; William D Foulkes; Nassim Taherian; Marielle Ruijs; Apollonia T Helderman-van den Enden; Louise Izatt; Rosemarie Davidson; Muriel A Adank; Lisa Walker; Rita Schmutzler; Kathy Tucker; Judy Kirk; Shirley Hodgson; Marion Harris; Fiona Douglas; Geoffrey J Lindeman; Janez Zgajnar; Marc Tischkowitz; Virginia E Clowes; Rachel Susman; Teresa Ramón y Cajal; Nicholas Patcher; Neus Gadea; Allan Spigelman; Theo van Os; Annelie Liljegren; Lucy Side; Carole Brewer; Angela F Brady; Alan Donaldson; Vigdis Stefansdottir; Eitan Friedman; Rakefet Chen-Shtoyerman; David J Amor; Lucia Copakova; Julian Barwell; Veda N Giri; Vedang Murthy; Nicola Nicolai; Soo-Hwang Teo; Lynn Greenhalgh; Sara Strom; Alex Henderson; John McGrath; David Gallagher; Neil Aaronson; Audrey Ardern-Jones; Chris Bangma; David Dearnaley; Philandra Costello; Jorunn Eyfjord; Jeanette Rothwell; Alison Falconer; Henrik Gronberg; Freddie C Hamdy; Oskar Johannsson; Vincent Khoo; Zsofia Kote-Jarai; Jan Lubinski; Ulrika Axcrona; Jane Melia; Joanne McKinley; Anita V Mitra; Clare Moynihan; Gad Rennert; Mohnish Suri; Penny Wilson; Emma Killick; Sue Moss; Rosalind A Eeles
Journal:  Eur Urol       Date:  2014-01-15       Impact factor: 20.096

5.  Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.

Authors:  Elena Castro; Chee Goh; David Olmos; Ed Saunders; Daniel Leongamornlert; Malgorzata Tymrakiewicz; Nadiya Mahmud; Tokhir Dadaev; Koveela Govindasami; Michelle Guy; Emma Sawyer; Rosemary Wilkinson; Audrey Ardern-Jones; Steve Ellis; Debra Frost; Susan Peock; D Gareth Evans; Marc Tischkowitz; Trevor Cole; Rosemarie Davidson; Diana Eccles; Carole Brewer; Fiona Douglas; Mary E Porteous; Alan Donaldson; Huw Dorkins; Louise Izatt; Jackie Cook; Shirley Hodgson; M John Kennedy; Lucy E Side; Jacqueline Eason; Alex Murray; Antonis C Antoniou; Douglas F Easton; Zsofia Kote-Jarai; Rosalind Eeles
Journal:  J Clin Oncol       Date:  2013-04-08       Impact factor: 44.544

  5 in total
  7 in total

1.  Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Authors:  Valentina Silvestri; Goska Leslie; Daniel R Barnes; Bjarni A Agnarsson; Kristiina Aittomäki; Elisa Alducci; Irene L Andrulis; Rosa B Barkardottir; Alicia Barroso; Daniel Barrowdale; Javier Benitez; Bernardo Bonanni; Ake Borg; Saundra S Buys; Trinidad Caldés; Maria A Caligo; Carlo Capalbo; Ian Campbell; Wendy K Chung; Kathleen B M Claes; Sarah V Colonna; Laura Cortesi; Fergus J Couch; Miguel de la Hoya; Orland Diez; Yuan Chun Ding; Susan Domchek; Douglas F Easton; Bent Ejlertsen; Christoph Engel; D Gareth Evans; Lidia Feliubadalò; Lenka Foretova; Florentia Fostira; Lajos Géczi; Anne-Marie Gerdes; Gord Glendon; Andrew K Godwin; David E Goldgar; Eric Hahnen; Frans B L Hogervorst; John L Hopper; Peter J Hulick; Claudine Isaacs; Angel Izquierdo; Paul A James; Ramunas Janavicius; Uffe Birk Jensen; Esther M John; Vijai Joseph; Irene Konstantopoulou; Allison W Kurian; Ava Kwong; Elisabetta Landucci; Fabienne Lesueur; Jennifer T Loud; Eva Machackova; Phuong L Mai; Keivan Majidzadeh-A; Siranoush Manoukian; Marco Montagna; Lidia Moserle; Anna Marie Mulligan; Katherine L Nathanson; Heli Nevanlinna; Joanne Ngeow; Liene Nikitina-Zake; Kenneth Offit; Edith Olah; Olufunmilayo I Olopade; Ana Osorio; Laura Papi; Sue K Park; Inge Sokilde Pedersen; Pedro Perez-Segura; Annabeth H Petersen; Pedro Pinto; Berardino Porfirio; Miquel Angel Pujana; Paolo Radice; Johanna Rantala; Muhammad U Rashid; Barak Rosenzweig; Maria Rossing; Marta Santamariña; Rita K Schmutzler; Leigha Senter; Jacques Simard; Christian F Singer; Angela R Solano; Melissa C Southey; Linda Steele; Zoe Steinsnyder; Dominique Stoppa-Lyonnet; Yen Yen Tan; Manuel R Teixeira; Soo H Teo; Mary Beth Terry; Mads Thomassen; Amanda E Toland; Sara Torres-Esquius; Nadine Tung; Christi J van Asperen; Ana Vega; Alessandra Viel; Jeroen Vierstraete; Barbara Wappenschmidt; Jeffrey N Weitzel; Greet Wieme; Sook-Yee Yoon; Kristin K Zorn; Lesley McGuffog; Michael T Parsons; Ute Hamann; Mark H Greene; Judy A Kirk; Susan L Neuhausen; Timothy R Rebbeck; Marc Tischkowitz; Georgia Chenevix-Trench; Antonis C Antoniou; Eitan Friedman; Laura Ottini
Journal:  JAMA Oncol       Date:  2020-08-01       Impact factor: 31.777

2.  Painting a portrait: Analysis of national health survey data for cancer genetic counseling.

Authors:  Monica H Stamp; Ora K Gordon; Christopher P Childers; Kimberly K Childers
Journal:  Cancer Med       Date:  2019-02-07       Impact factor: 4.452

3.  Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.

Authors:  Samantha Greenberg; Saundra S Buys; Sandra L Edwards; Whitney Espinel; Alison Fraser; Amanda Gammon; Brent Hafen; Kimberly A Herget; Wendy Kohlmann; Camille Roundy; Carol Sweeney
Journal:  Cancer Med       Date:  2019-09-18       Impact factor: 4.452

4.  BRCA1 and BRCA2 Gene Mutations and Lung Cancer Sisk: A Meta-Analysis.

Authors:  Yen-Chien Lee; Yang-Cheng Lee; Chung-Yi Li; Yen-Ling Lee; Bae-Ling Chen
Journal:  Medicina (Kaunas)       Date:  2020-04-27       Impact factor: 2.430

Review 5.  Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications.

Authors:  Andreia Brandão; Paula Paulo; Manuel R Teixeira
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

6.  Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor survey.

Authors:  Peng Sun; Yue Li; Xue Chao; Jibin Li; Rongzhen Luo; Mei Li; Jiehua He
Journal:  BMC Cancer       Date:  2020-10-14       Impact factor: 4.430

Review 7.  Genetic predisposition to prostate cancer: an update.

Authors:  Holly Ni Raghallaigh; Rosalind Eeles
Journal:  Fam Cancer       Date:  2021-01-24       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.